Publication:
Randomized Study to Evaluate the Impact of Telemedicine Care in Patients With Type 1 Diabetes With Multiple Doses of Insulin and Suboptimal HbA1c in Andalusia (Spain): PLATEDIAN Study.

dc.contributor.authorRuiz de Adana, Maria S
dc.contributor.authorAlhambra-Exposito, Maria Rosa
dc.contributor.authorMuñoz-Garach, Araceli
dc.contributor.authorGonzalez-Molero, Inmaculada
dc.contributor.authorColomo, Natalia
dc.contributor.authorTorres-Barea, Isabel
dc.contributor.authorAguilar-Diosdado, Manuel
dc.contributor.authorCarral, Florentino
dc.contributor.authorSerrano, Manuel
dc.contributor.authorMartinez-Brocca, Maria A
dc.contributor.authorDuran, Ana
dc.contributor.authorPalomares, Rafael
dc.contributor.funderAndalusian Society of Endocrinology, Diabetes, and Nutrition (SAEDYN)
dc.contributor.funderSpanish Ministry of Economy and Competitiveness
dc.contributor.groupDiabetes Group of SAEDYN (Andalusian Society of Endocrinology, Diabetes, and Nutrition)
dc.date.accessioned2023-02-08T14:38:22Z
dc.date.available2023-02-08T14:38:22Z
dc.date.issued2019-12-16
dc.description.abstractTo assess the impact of a telemedicine visit using the platform Diabetic compared with a face-to-face visit on clinical outcomes, patients' health-related quality of life (HRQoL), and physicians' satisfaction in patients with type 1 diabetes. PLATEDIAN (Telemedicine on Metabolic Control in Type 1 Diabetes Mellitus Andalusian Patients) (NCT03332472) was a multicenter, randomized, 6-month follow-up, open-label, parallel-group controlled study performed in patients with type 1 diabetes with suboptimal metabolic control (HbA1c At month 6, the mean change in HbA1c levels was -0.04 ± 0.5% (-0.5 ± 5.8 mmol/mol) in the CC and 0.01 ± 0.6% (0.1 ± 6.0 mmol/mol) in the IC (P = 0.4941). The number of patients who achieved HbA1c The use of telemedicine in patients with type 1 diabetes with HbA1cc <8% (<64 mmol/mol) provides similar efficacy and safety outcomes as face-to-face visits.
dc.description.versionSi
dc.identifier.citationRuiz de Adana MS, Alhambra-Expósito MR, Muñoz-Garach A, Gonzalez-Molero I, Colomo N, Torres-Barea I, et al. Randomized Study to Evaluate the Impact of Telemedicine Care in Patients With Type 1 Diabetes With Multiple Doses of Insulin and Suboptimal HbA1c in Andalusia (Spain): PLATEDIAN Study. Diabetes Care. 2020 Feb;43(2):337-342
dc.identifier.doi10.2337/dc19-0739
dc.identifier.essn1935-5548
dc.identifier.pmid31831473
dc.identifier.urihttp://hdl.handle.net/10668/14823
dc.issue.number2
dc.journal.titleDiabetes care
dc.language.isoen
dc.organizationHospital Universitario de Puerto Real
dc.organizationÁrea de Gestión Sanitaria de Jerez, Costa Noroeste y Sierra de Cádiz
dc.organizationHospital Universitario Puerta del Mar
dc.organizationInstituto de Investigación e Innovación en Ciencias Biomédicas
dc.organizationHospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba-IMIBIC
dc.organizationHospital Universitario de Jaén
dc.organizationHospital Universitario Virgen de la Victoria
dc.organizationHospital Universitario Regional de Málaga
dc.organizationInstituto de Investigación Biomédica de Málaga-IBIMA
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.organizationHospital Universitario Virgen del Rocío
dc.organizationHospital Universitario Virgen Macarena
dc.page.number337-342
dc.provenanceRealizada la curación de contenido 30/08/2024
dc.publisherAmerican Diabetes Association
dc.pubmedtypeJournal Article
dc.pubmedtypeMulticenter Study
dc.pubmedtypeRandomized Controlled Trial
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.relation.projectIDJR17/00023
dc.relation.publisherversionhttps://diabetesjournals.org/care/article-lookup/doi/10.2337/dc19-0739
dc.subjectÁrea de Gestión Sanitaria de Jerez, Costa Noroeste y Sierra de Cádiz
dc.subjectBlood glucose
dc.subjectDiabetes Mellitus, type 1
dc.subjectDose-response relationship, drug
dc.subjectFollow-up studies
dc.subjectGlycated hemoglobin
dc.subject.decsAtención primaria de salud
dc.subject.decsCalidad de vida
dc.subject.decsHipoglucemia
dc.subject.decsInsulina
dc.subject.decsInyecciones
dc.subject.decsTelemedicina
dc.subject.decsVisita a consultorio médico
dc.subject.meshHumans
dc.subject.meshHypoglycemia
dc.subject.meshHypoglycemic Agents
dc.subject.meshInjections
dc.subject.meshInsulin
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshOffice Visits
dc.subject.meshPrimary Health Care
dc.subject.meshQuality of Life
dc.subject.meshSpain
dc.subject.meshTelemedicine
dc.subject.meshTreatment Outcome
dc.subject.meshYoung Adult
dc.titleRandomized Study to Evaluate the Impact of Telemedicine Care in Patients With Type 1 Diabetes With Multiple Doses of Insulin and Suboptimal HbA1c in Andalusia (Spain): PLATEDIAN Study.
dc.typeresearch article
dc.volume.number43
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
RISalud_Accesorestringido.pdf
Size:
93.39 KB
Format:
Adobe Portable Document Format